ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,070.55
      1.20%
      US Tech 100
      17,054.40
      1.80%
      Dow Jones
      38,503.69
      0.69%
      Brent Oil
      87.62
      1.40%
      Bitcoin
      66,317.78
      -0.81%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Inovio Pharmaceuticals Inc New (INO)

      7. Inovio Pharmaceuticals Inc New (INO) News

      INO

      Inovio Pharmaceuticals (INO)

      Inovio Pharmaceuticals Inc New
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:INO
      DateTimeSourceHeadlineSymbolCompany
      04/15/20246:39PMPR Newswire (US)INOVIO Announces Pricing of Approximately $36 Million Underwritten Offering of Common Stock and Pre-Funded WarrantsNASDAQ:INOInovio Pharmaceuticals Inc New
      03/26/20246:28PMPR Newswire (US)INOVIO to Participate in The Citizens JMP Novel Therapeutics Forum at Penn MedicineNASDAQ:INOInovio Pharmaceuticals Inc New
      03/06/20244:05PMPR Newswire (US)INOVIO Reports Fourth Quarter and Full Year 2023 Financial Results and Operational HighlightsNASDAQ:INOInovio Pharmaceuticals Inc New
      03/06/20247:00AMPR Newswire (US)Geneos Therapeutics to Present New Clinical Data on GNOS-PV02 at the 2024 American Association for Cancer Research (AACR) Annual MeetingNASDAQ:INOInovio Pharmaceuticals Inc New
      03/06/20246:02AMIH Market NewsU.S. Stock Futures Gain Ahead of Economic Insights; Oil Prices ClimbNASDAQ:INOInovio Pharmaceuticals Inc New
      02/21/20248:00AMPR Newswire (US)INOVIO to Report Fourth Quarter and Year-End 2023 Financial Results on March 6, 2024NASDAQ:INOInovio Pharmaceuticals Inc New
      02/07/202411:46AMPR Newswire (US)INOVIO to Present at the Oppenheimer 34th Annual Healthcare Life Sciences ConferenceNASDAQ:INOInovio Pharmaceuticals Inc New
      02/02/20248:00AMPR Newswire (US)INOVIO Reports Inducement Grant Under Inducement PlanNASDAQ:INOInovio Pharmaceuticals Inc New
      02/01/202412:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:INOInovio Pharmaceuticals Inc New
      01/26/20244:01PMEdgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NASDAQ:INOInovio Pharmaceuticals Inc New
      01/25/20244:02PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:INOInovio Pharmaceuticals Inc New
      01/23/20248:00AMPR Newswire (US)INOVIO Announces Effective Date of 1-for-12 Reverse Stock SplitNASDAQ:INOInovio Pharmaceuticals Inc New
      01/22/20248:00AMPR Newswire (US)INOVIO to Participate in Virtual Fireside Chat on the Potential Treatment of Recurrent Respiratory Papillomatosis with Key Opinion LeaderNASDAQ:INOInovio Pharmaceuticals Inc New
      01/12/20245:27PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:INOInovio Pharmaceuticals Inc New
      01/04/20248:00AMPR Newswire (US)INOVIO and Coherus Announce Clinical Collaboration to Advance Development of INO-3112 in Combination with LOQTORZI™ (toripalimab-tpzi)NASDAQ:INOInovio Pharmaceuticals Inc New
      01/03/20248:00AMPR Newswire (US)INOVIO Plans to Submit a BLA for INO-3107 as a Potential Treatment for RRP in Second Half of 2024 Under Accelerated Approval ProgramNASDAQ:INOInovio Pharmaceuticals Inc New
      11/28/20234:05PMEdgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:INOInovio Pharmaceuticals Inc New
      11/17/20234:00PMEdgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:INOInovio Pharmaceuticals Inc New
      11/09/20234:35PMEdgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:INOInovio Pharmaceuticals Inc New
      11/09/20234:15PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:INOInovio Pharmaceuticals Inc New
      11/09/20234:05PMPR Newswire (US)INOVIO Reports Third Quarter 2023 Financial Results and Operational HighlightsNASDAQ:INOInovio Pharmaceuticals Inc New
      11/09/20234:00PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:INOInovio Pharmaceuticals Inc New
      11/02/20234:01PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:INOInovio Pharmaceuticals Inc New
      11/01/20238:00AMPR Newswire (US)INOVIO Reports Inducement Grants Under Inducement PlanNASDAQ:INOInovio Pharmaceuticals Inc New
      10/26/20238:00AMPR Newswire (US)INOVIO to Report Third Quarter 2023 Financial Results on November 9, 2023NASDAQ:INOInovio Pharmaceuticals Inc New
      10/10/20234:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:INOInovio Pharmaceuticals Inc New
      10/10/202310:51AMDow Jones NewsInovio Shares Rise 8% After FDA Feedback for INO-3107NASDAQ:INOInovio Pharmaceuticals Inc New
      10/10/20238:00AMPR Newswire (US)INOVIO Receives FDA Feedback that Data from Completed Phase 1/2 Trial of INO-3107 Can Be Used to Submit a BLA Under Accelerated Approval ProgramNASDAQ:INOInovio Pharmaceuticals Inc New
      09/27/20237:39PMPR Newswire (US)Geneos Therapeutics Closes its Series A3 Financing With Investment of $5 MillionNASDAQ:INOInovio Pharmaceuticals Inc New
      09/07/20238:00AMPR Newswire (US)INOVIO Announces U.S. FDA Breakthrough Therapy Designation Granted for INO-3107 for the Treatment of Recurrent Respiratory PapillomatosisNASDAQ:INOInovio Pharmaceuticals Inc New
       Showing the most relevant articles for your search:NASDAQ:INO